2cureX German subsidiary receives a grant contribution to support the activities towards automation of the IndiTreat® test
Copenhagen — April 29, 2020 — 2cureX AB (“2cureX”, NASDAQ: 2CUREX) announced today that the company’s German subsidiary 2cureX GmbH (“2cureX”) has received a grant from the German Federal Ministry of Education and Research to co-develop an automated system for handling and deposition of 3D-micro-tumors (tumoroids) into 2cureX’s IndiTreat® test system. This project is conducted in collaboration with Hahn-Schickard and the Department of Microsystems Engineering (“IMTEK”) at the University of Freiburg. Inlägget 2cureX German subsidiary receives a grant contribution to support the activities towards automation of the IndiTreat® test dök först upp på IPO. se.
